You Searched For "bharat biotech coronavirus vaccine" and got 20 results
Sort By:
BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General
The Indian Council of Medical Research Director General Dr Rajiv Bahl has criticised a recently pub…
PTI
Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN
Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged…
PTI
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
Bharat Biotech's nasal Covid vaccine to be priced at ₹800 for private and ₹325 for govt hospitals
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will …
ANI
Bharat Biotech’s Covaxin shows 81% efficacy after second dose in phase 3 trials
Hyderabad-based Bharat Biotech released phase 3 results of its Covid-19 vaccine — Covaxin — today. …
Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …
Ideal time for COVID-19 booster shot is six months after the second dose, says Bharat Biotech MD
"The ideal time for a booster dose is six months after the second dose," Ella stated. Abo…
PTI
Bharat Biotech working on TB vaccine, to ink pact with a firm for technology
"Our honourable Prime Minister (Narendra Modi) has got an agenda of 2025 for the eradication of tub…
PTI
WHO approves Bharat Biotech’s Covaxin for emergency use after a long wait
The WHO, in a tweet, said: "WHO has granted emergency use listing (EUL) to Covaxin, developed by…
COVID-19 vaccine Covaxin: Bharat Biotech to begin Phase II trials soon
These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants,…
Expert panel of India's drug regulator mulling Bharat Biotech's nasal vaccine trial proposal
A meeting of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation …
COVID-19 vaccine latest updates: Astrazeneca’s manufacturing ‘error’ raises concerns on vaccine efficacy, Covaxin to begin phase III trials in Gujarat
The latest wave of COVID-19 infections across the world has taken the global tally of cases over th…
It's open season for coronavirus vaccine boosters
These are Insider's biggest healthcare stories for September 27.
Leah Rosenbaum
Supreme Court wants the Indian government to explain vaccine pricing — and clarify how many doses it will need as coverage expands from May 1
The Supreme Court of India has decided it cannot be a “mute spectator” as the number of new COVID-1…
Hyderabad : Vaccine capital of the world
This southern city, already recognised as a global information technology destination, proved …
Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January
The pharma giant is on track to have a new version of its vaccine ready by late March, its chief sc…
Andrew Dunn
Health Ministry rejects claim 'Covaxin was rushed due to political pressure'
The Union Health Ministry on Thursday rejected media reports that Covaxin manufacturer Bharat Biote…
COVID-19 vaccine latest updates: Spain approves phase III trials of J&J vaccine, Feluda test kit for COVID to be launched in Delhi
The latest wave of COVID-19 infections across the world has taken the global tally of cases over th…
COVID-19 vaccine latest updates: Sinovac’s CoronaVac safe, early trial results show that vaccine triggers immune response
It takes a decade or two to design, test, and launch an effective vaccine that can protect billi…
Here's the data we have so far on the Omicron variant versus our vaccines — what scientists have found, and what remains unanswered
The first lab findings are flying in from scientists around the world. Here's what we know so far o…